Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 5
1981 2
1982 7
1983 5
1984 8
1985 15
1986 20
1987 27
1988 27
1989 31
1990 39
1991 42
1992 46
1993 64
1994 93
1995 62
1996 80
1997 109
1998 101
1999 89
2000 101
2001 134
2002 140
2003 181
2004 141
2005 160
2006 188
2007 150
2008 144
2009 123
2010 118
2011 125
2012 99
2013 98
2014 109
2015 101
2016 86
2017 77
2018 87
2019 81
2020 76
2021 77
2022 62
2023 58
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

3,351 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean pamidronate OR Pamidronic acid (3,352 results)?
Updates on Paget's Disease of Bone.
Choi YJ, Sohn YB, Chung YS. Choi YJ, et al. Endocrinol Metab (Seoul). 2022 Oct;37(5):732-743. doi: 10.3803/EnM.2022.1575. Epub 2022 Oct 25. Endocrinol Metab (Seoul). 2022. PMID: 36327984 Free PMC article.
The diagnosis is frequently confirmed by radiographic and nuclear scintigraphy of the bone. Further, bisphosphonates such as zoledronic acid and pamidronate are effective for its treatment. Moreover, biochemical monitoring is superior to the symptoms as a recurrence …
The diagnosis is frequently confirmed by radiographic and nuclear scintigraphy of the bone. Further, bisphosphonates such as zoledronic a …
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
Major P, Lortholary A, Hon J, Abdi E, Mills G, Menssen HD, Yunus F, Bell R, Body J, Quebe-Fehling E, Seaman J. Major P, et al. J Clin Oncol. 2001 Jan 15;19(2):558-67. doi: 10.1200/JCO.2001.19.2.558. J Clin Oncol. 2001. PMID: 11208851
RESULTS: Two hundred eighty-seven patients were randomized and evaluated for safety; 275 were evaluated for efficacy. Both doses of zoledronic acid were superior to pamidronate in the treatment of HCM. The complete response rates by day 10 were 88.4% (P = .002), 86. …
RESULTS: Two hundred eighty-seven patients were randomized and evaluated for safety; 275 were evaluated for efficacy. Both doses of zoledron …
Atrial fibrillation in patients treated with intravenous zoledronic or pamidronic acid: a pharmacoepidemiological study.
Pijnenburg L, Salem JE, Lebrun-Vignes B, Sibilia J, Javier RM, Arnaud L. Pijnenburg L, et al. Eur J Endocrinol. 2021 Mar;184(3):437-444. doi: 10.1530/EJE-20-0650. Eur J Endocrinol. 2021. PMID: 33449911
OBJECTIVE: Atrial fibrillation (AF) may be triggered by intravenous bisphosphonates (IVBPs) such as zoledronic acid or pamidronic acid. Our objective was to confirm the association between AF and IVBPs in a real-life large pharmacovigilance database. ...Most …
OBJECTIVE: Atrial fibrillation (AF) may be triggered by intravenous bisphosphonates (IVBPs) such as zoledronic acid or pamidronic …
Preparation, Optimisation, and In Vitro Evaluation of [(18)F]AlF-NOTA-Pamidronic Acid for Bone Imaging PET.
Hassan H, Othman MF, Abdul Razak HR, Zakaria ZA, Ahmad Saad FF, Osman MA, Yi LH, Ashhar Z, Idris J, Abdul Hamid MHN, Safee ZM. Hassan H, et al. Molecules. 2022 Nov 17;27(22):7969. doi: 10.3390/molecules27227969. Molecules. 2022. PMID: 36432069 Free PMC article.
NOTA-pamidronic acid was successfully prepared and radiolabeled with (18)F. ...It was found that [(18)F]NaF was higher in both cell lines, but [(18)F]AlF-NOTA-pamidronic acid showed promising cellular uptake in Saos-2. The preliminary results suggest t …
NOTA-pamidronic acid was successfully prepared and radiolabeled with (18)F. ...It was found that [(18)F]NaF was higher in both …
Preparation, Characterization, and Radiolabeling of [(68)Ga]Ga-NODAGA-Pamidronic Acid: A Potential PET Bone Imaging Agent.
Ashhar Z, Yusof NA, Ahmad Saad FF, Mohd Nor SM, Mohammad F, Bahrin Wan Kamal WH, Hassan MH, Ahmad Hassali H, Al-Lohedan HA. Ashhar Z, et al. Molecules. 2020 Jun 9;25(11):2668. doi: 10.3390/molecules25112668. Molecules. 2020. PMID: 32526838 Free PMC article.
For that, we prepared, thoroughly characterized, and radiolabeled [(68)Ga]Ga-NODAGA-pamidronic acid radiopharmaceutical, a (68)Ga precursor for PET bone cancer imaging applications. ...From previous work, we found that the pamidronic acid itself has a …
For that, we prepared, thoroughly characterized, and radiolabeled [(68)Ga]Ga-NODAGA-pamidronic acid radiopharmaceutical, a (68 …
The Effects of Polyphenol, Tannic Acid, or Tannic Acid in Combination with Pamidronate on Human Osteoblast Cell Line Metabolism.
Hapidin H, Hashim NM, Kasiram MZ, Abdullah H. Hapidin H, et al. Molecules. 2022 Jan 11;27(2):451. doi: 10.3390/molecules27020451. Molecules. 2022. PMID: 35056766 Free PMC article.
BACKGROUND: This study investigates the effect of tannic acid (TA) combined with pamidronate (PAM) on a human osteoblast cell line. ...
BACKGROUND: This study investigates the effect of tannic acid (TA) combined with pamidronate (PAM) on a human osteoblast cell …
Ocular Side Effects of Bisphosphonates: A Review of Literature.
Chartrand NA, Lau CK, Parsons MT, Handlon JJ, Ronquillo YC, Hoopes PC, Moshirfar M. Chartrand NA, et al. J Ocul Pharmacol Ther. 2023 Jan-Feb;39(1):3-16. doi: 10.1089/jop.2022.0094. Epub 2022 Nov 21. J Ocul Pharmacol Ther. 2023. PMID: 36409537 Review.
Only 2nd- and 3rd-generation amino bisphosphonates, including pamidronate, alendronate, risedronate, ibandronate, and zoledronate are associated with these complications. The mechanism of bisphosphonate-induced ocular inflammation may be related to activation of gamma/delt …
Only 2nd- and 3rd-generation amino bisphosphonates, including pamidronate, alendronate, risedronate, ibandronate, and zoledronate are …
Treatment-Refractory Sternocostoclavicular Hyperostosis.
Yachoui R, Kreidy M, Parker BJ. Yachoui R, et al. Clin Med Res. 2017 Jun;15(1-2):37-40. doi: 10.3121/cmr.2017.1352. Clin Med Res. 2017. PMID: 28751466 Free PMC article.
There have been several reports in which intravenous bisphosphonates and tumor necrosis factor-inhibitors have shown reasonable efficacy in the treatment of this disorder. We report a patient with a long history of SCCH in whom pamidronate 60 mg intravenously every 3 month …
There have been several reports in which intravenous bisphosphonates and tumor necrosis factor-inhibitors have shown reasonable efficacy in …
3,351 results